Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden

References

• MaierPCFunkJSchwartzerGAnterGFalck-YtterYTTreatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trialsBMJ200533113415994659
   PubMed Web of Science ®Google Scholar
• The AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol200013042944011024415
   PubMed Web of Science ®Google Scholar
• ChengJWWeiRLMeta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressureClin Ther20083062263218498911
   PubMed Web of Science ®Google Scholar
• DenisPLaunoisRDevauxMBerdeauxGComparison of diurnal intraocular pressure control by latanoprost versus travoprost: results of an observational surveyClin Drug Investig200626703714
   PubMed Web of Science ®Google Scholar
• DirksMSNoeckerRJEarlMRohSWilliamsRDA 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucomaAdv Ther20062338539416912020
   PubMed Web of Science ®Google Scholar
• DubinerHBSircyMDLandryTComparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressureClin Ther200426849114996520
   PubMed Web of Science ®Google Scholar
• García-FeijooJMartínez-de-la-CasaJMCastilloAMéndezCFernández-VidalAGarcía-SánchezJCircadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%Curr Med Res Opin2006221689169716968572
   PubMed Web of Science ®Google Scholar
• HepsenIFOzkayaE24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertensionEye20072145345816543930
   PubMed Web of Science ®Google Scholar
• KonstasAGHollóGIrkecMDiurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre studyBr J Ophthalmol20079175776017124241
   PubMed Web of Science ®Google Scholar
• KonstasAGKozobolisVPKatsimprisIEEfficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patientsOphthalmol2007114653657
   PubMed Web of Science ®Google Scholar
• KozOGOzsoyAYarangumeliAKoseSKKuralGComparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trialActa Ophthalmol Scand20078583884317680841
   PubMedGoogle Scholar
• MartinezASanchezMBimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patientsEye20092381081818535605
   PubMed Web of Science ®Google Scholar
• NetlandPALandryTSullivanEKTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol200113247248411589866
   PubMed Web of Science ®Google Scholar
• NoeckerRSDirksMSChoplinNTA six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucomaAm J Ophthalmol2003135556312504698
   PubMed Web of Science ®Google Scholar
• OrzalesiNRossettiLBottoliAFogagnoloPComparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intra-ocular pressure in patients with glaucoma or ocular hypertensionOphthalmol2006113239246
   PubMed Web of Science ®Google Scholar
• ParrishRKPalmbergPSheuWPXLT Study GroupA comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter studyAm J Ophthalmol200313568870312719078
   PubMed Web of Science ®Google Scholar
• QuarantaLPizzolanteTRivaIHaidichABKonstasAGStewartWCTwenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucomaBr J Ophthalmol2008921227123118586898
   PubMed Web of Science ®Google Scholar
• TopouzisFMelamedSDanesh-MeyerHA 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionEur J Ophthalmol20071718319017415690
   PubMed Web of Science ®Google Scholar
• DenisPLafumaAKhoshnoodBMimaudVBerdeauxGA meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapyCurr Med Res Opin20072360160817355741
   PubMed Web of Science ®Google Scholar
• FrenkelREPFrenkelMTolerAPharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertensionBMC Ophthalmol200771617900371
   PubMedGoogle Scholar
• GaoYWuLLiADaily cost of glaucoma medications in ChinaJ Glaucoma20071659459718091176
   PubMed Web of Science ®Google Scholar
• FiscellaRGGreenAPatuszynskiDHWilenskyJMedical therapy cost considerations for glaucomaAm J Ophthalmol2003136182512834665
   PubMed Web of Science ®Google Scholar
• RylanderNRVoldSDCost analysis of glaucoma medicationsAm J Ophthalmol200814510611318154755
   PubMed Web of Science ®Google Scholar
• Azuara-BlancoABurrJThe rising cost of glaucoma drugsBr J Ophthalmol20069013013116424517
   PubMed Web of Science ®Google Scholar
• VidalEdition du VidalParis2008
   Google Scholar
• Rote List. http://www.rote-liste.de
   Google Scholar
• Social Insurance Institution. Kela. Medicinal products database. http://asiakas.kela.fi/laakekys_app/LaakekysApplication?kieli=en
   Google Scholar
• TLV. Tandvårds- och läkemedelsförmånsverket. http://www.tlv.se/in-english/price-database/
   Google Scholar
• Laegemiddel Styrelsen. Danish Medicines Agency. Medicinpriser.dk. http://www.medicinpriser.dk/
   Google Scholar
• MishimaSGassetAKlyceSDBaumJLDetermination of tear volume and tear flowInvest Ophthalmol196652642765947945
   PubMedGoogle Scholar
• EhlersNThe precorneal film. Biomicroscopical and chemical investigationsActa Ophthalmol1965Suppl 811134
   Google Scholar
• MishimaSClinical pharmacokinetics of the eye. Proctor lectureInvest Ophthalmol Vis Sci1981215045416116682
   PubMed Web of Science ®Google Scholar
• ChraiSMakoidMEriksenSRobinsonJDrop size and initial dosing frequency problems of topically applied ophthalmic drugsJ Pharm Sci1974633333384820359
   PubMed Web of Science ®Google Scholar
• ShellJOphthalmic drug delivery systemsSurv Ophthalmol19842917791828
   Web of Science ®Google Scholar
• UrttiASalminenLMinimizing systemic absorption of topically administered ophthalmic drugsSurv Ophthalmol1993374354568100087
   PubMed Web of Science ®Google Scholar
• Van SantvlietLLudwigADeterminants of eye drop sizeSurv Ophthalmol20044919721314998692
   PubMed Web of Science ®Google Scholar
• TsaiTRobinALSmithJP3rdAn evaluation of how glaucoma patients use topical medications: a pilot studyTrans Am Ophthalmol Soc20071052933Discussion 33–35.18427591
   PubMedGoogle Scholar
• RobinALNovackGDCovertDWCrockettRSMarcicTSAdherence in glaucoma: objective measurements of once-daily and adjunctive medication useAm J Ophthalmol200714453354017686450
   PubMed Web of Science ®Google Scholar
• SleathBRobinALCovertDByrdJETudorGSvarstadBPatient-reported behavior and problems in using glaucoma medicationsOphthalmol2006113431436
   PubMed Web of Science ®Google Scholar
• LafumaABerdeauxGCosts and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research DatabaseCurr Med Res Opin2007233009301617958945
   PubMed Web of Science ®Google Scholar
• DenisPLafumaABerdeauxGMedical predictive factors of glaucoma treatment costsJ Glaucoma20041328329015226656
   PubMed Web of Science ®Google Scholar
• DenisPLe PenCUmuhireDBerdeauxGTreatment carryover impacts on effectiveness of intraocular pressure lowering agents, estimated by a discrete event simulation modelEur J Ophthalmol200818445118203084
   PubMed Web of Science ®Google Scholar
• TraversoCEWaltJGSternLSDolgitserMPharmacotherapy compliance in patients with ocular hypertension or primary open-angle glaucomaJ Ocul Pharmacol Ther200925778219232009
   PubMed Web of Science ®Google Scholar
• HollóGKóthyPGéczyAVarghaPPersonality traits, depression, and objectively measured adherence to once-daily prostaglandin analog medication in glaucomaJ Glaucoma20091828829219365193
   PubMed Web of Science ®Google Scholar